{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000347.3:c.88G>C",
          "cDNA Change": {
            "transcript": "NM_000347.3",
            "ref": "G",
            "alt": "C",
            "position": "88"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "c.88G>C (p.Ala30Pro)"
        },
        {
          "HGVS": "NM_000347.3:c.136G>A",
          "cDNA Change": {
            "transcript": "NM_000347.3",
            "ref": "G",
            "alt": "A",
            "position": "136"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "c.136G>A (p.Glu46Lys)"
        },
        {
          "HGVS": "NM_000347.3:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000347.3",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "c.157G>A (p.Ala53Thr)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005071"
  },
  "Experiment Method": [
    {
      "Assay Method": "Solution NMR Spectroscopy",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Human wild-type and mutant α-synuclein",
        "Description": "Human wild-type α-synuclein with 15N and 2H isotopic enrichment was expressed and purified by anion-exchange chromatography. A30P, E46K, and A53T α-synuclein were expressed from recombinant plasmids produced by mutagenesis of the wild-type sequence."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000347.3:c.88G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The A30P mutation results in lower helical propensity and disrupted membrane interactions, leading to a reduced binding affinity for lipids."
        },
        {
          "Variant": "NM_000347.3:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46K mutation increases the level of phospholipid binding and assembly into filaments, leading to higher SL1 levels."
        },
        {
          "Variant": "NM_000347.3:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The A53T mutation exhibits a lower helix propensity combined with a membrane affinity comparable to that of the wild type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Multiple independent experiments were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed multiple times."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Lipid-free α-synuclein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Signal intensity attenuation within 20-30% for lipid-bound state.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Signal intensity attenuation > 50% for lipid-bound state.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}